Trypsin inhibitory effect of wedelolactone and demethylwedelolactone

Phytotherapy Research

Volumn 17, Issue 4, 2003, Pages 420-421

  Syed, Samiulla D ^a   Deepak, Mundkinajeddu ^a   Yogisha, Shivanna ^a   Chandrashekar, Arun P ^a   Muddarachappa, Keerthi A ^a   D'Souza, Prashanth ^a   Agarwal, Amit ^a   Venkataraman, B V ^b  

^a Natural Remedies Pvt Ltd   (India)

^b ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

Demethylwedelolactone; Eclipta alba; Trypsin inhibition; Wedelolactone

Indexed keywords

DEMETHYLWEDELOLACTONE; ECLIPTA ALBA EXTRACT; LEUPEPTIN; TRYPSIN INHIBITOR; UNCLASSIFIED DRUG; WEDELOLACTONE;

ARTICLE; DRUG ACTIVITY; DRUG ISOLATION; DRUG POTENCY; IC 50; IN VITRO STUDY; INHIBITION KINETICS;

ANIMALS; CHICKENS; COUMARINS; ECLIPTA; HUMANS; INHIBITORY CONCENTRATION 50; OVUM; PHYTOTHERAPY; PLANT EXTRACTS; PROTEASE INHIBITORS; TRYPSIN;

ECLIPTA PROSTRATA;

EID: 0037545766     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1153     Document Type: Article

References (5)

1. Cannell RJP, Kellam SJ, Owsianka AM, Walker JM. 1988. Results of a large scale screen of microalgae for the production of protease inhibitors. Planta Med 54: 10-14.
2. Chandra T, Sadique J, Somasundaram S. 1987. Effect of Eclipta alba on inflammation and liver injury. Fitoterapia 58: 23-32.
3. Ma-Ma K, Nyunt N, Tin NM. 1978. The protective effect of Eclipta alba on carbon tetrachloride-induced acute liver damage. Toxicol Appl Pharmacol 45: 723-728.
4. Wagner H, Fessler B. 1986. In-vitro 5-lipoxygenase inhibition by Eclipta alba extracts and the coumestan derivative wedelolactone. Planta Med 5: 374-377.
5. Wagner H, Geyer B, Kiso Y, Hikino H, Rao GS. 1986. Coumestans as the main active principles of the liver drugs Eclipta alba and Wedelia calendulacea. Planta Med 5: 370-374.